Biomedical Research and Training Institute, Zimbabwe
11
2
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
9.1%
1 terminated/withdrawn out of 11 trials
85.7%
-0.8% vs industry average
27%
3 trials in Phase 3/4
17%
1 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Xpert Active Case-finding Trial 3 (XACT-3)
Role: collaborator
Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)
Role: collaborator
Harnessing Male Peer Networks to Enhance Engagement With HIV Prevention
Role: collaborator
Using Machine Learning to Model Early-onset Neonatal Sepsis Risk in Uganda and Zimbabwe
Role: collaborator
Manicaland VMMC Uptake Through Behavioural Incentives Trial
Role: collaborator
Manicaland PrEP Uptake Through Interactive Counselling Trial
Role: collaborator
Syphilis Self-testing to Expand Test Uptake Among Men Who Have Sex With Men (SST)
Role: collaborator
Evaluating the NeoTree in Malawi and Zimbabwe
Role: collaborator
Orphans and Vulnerable Children Risk Screening Tool Research Study (Zimbabwe)
Role: collaborator
Community Based Antiretroviral Therapy (CBART) Among Children on Chronic ART
Role: lead
Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children
Role: collaborator
All 11 trials loaded